-
She may be an ideal candidate for thrombolytic therapy: A woman tells triage nurses that she first noticed symptoms exactly two hours ago. But by the time the patient is appropriately assessed, the window of time for eligibility to be treated with thrombolytics has passed. Has this occurred in your ED recently? Currently, only 2-5% of all eligible patients receive the thrombolytic drug t-PA, which was approved in 1996 for treatment of ischemic stroke within three hours of symptom onset.
-
If asked, How do you ensure that patients are not mistakenly identified before medications are given? during an accreditation survey, would every nurse in your ED be able to answer the question?
-
One way to make sure discharge planners, physicians, and other referral sources continue to send you new patients is to make sure your patients and their family members are happy with your services.
-
In response to the unacceptably low influenza immunization rates among health care workers, the Association for Professionals in Infection Control and Epidemiology (APIC) issued specific recommendations to health care facilities to develop and implement comprehensive influenza vaccination programs for employees.
-
Question: Do the security regulations address wireless security? How does an organization make sure any of its wireless devices are in compliance with HIPAA regulations?
-
Educating physicians about the cost-effective, high-quality care provided by your agency is only half of the marketing equation. Patients are the other half; and in many ways, theyre a tougher nut to crack.
-
-
Any time the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) adds a new requirement to the survey process, quality professionals are obligated to become conversant with it to ramp up for their next survey. But if thats all the new tools are used for, they may be missing significant opportunities for improvement, experts argue. Such is the case with tracer methodology.
-
The means by which prions cause neuropathologic damage remains to be established.
-
The MATCH data provide quite strong evidence that the clopidogrel-aspirin combination is a less favorable option than previously thought, but its use may not be completely contraindicated.
